about
Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in MicePotential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis.Occurrence of Neuroblastoma among TP53 p.R337H Carriers.Simultaneous detection of lysine metabolites by a single LC-MS/MS method: monitoring lysine degradation in mouse plasma.Downregulation of 14q32 microRNAs in Primary Human Desmoplastic MedulloblastomaHIF1A is overexpressed in medulloblastoma and its inhibition reduces proliferation and increases EPAS1 and ATG16L1 methylation.IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis.Unraveling the expression of the oncogene YAP1, a Wnt/beta-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients.Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.Sonic hedgehog signaling is active in human adrenal cortex development and deregulated in adrenocortical tumors.Hypoxia-related gene expression profile in childhood acute lymphoblastic leukemia: prognostic implications.Assessment of BCL2/J(H) translocation in healthy individuals exposed to low-level radiation of 137CsCl in Goiânia, Goiás, Brazil.The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.Oral Mucositis in Pediatric Acute Lymphoblastic Leukemia Patients: Evaluation of Microbiological and Hematological Factors.Comparison between qualitative and real-time polymerase chain reaction to evaluate minimal residual disease in children with acute lymphoblastic leukemiaCorrection: Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice.CAISMOV24, a new human low-grade serous ovarian carcinoma cell line.Mouse lysine catabolism to aminoadipate occurs primarily through the saccharopine pathway; implications for pyridoxine dependent epilepsy (PDE).Adrenocortical tumors associated with the TP53 p.R337H germline mutation can be identified during child-care consultations.Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): Overexpression of Aurora kinases A and B is associated with a poor prognosis.Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.Low Bioavailability and High Immunogenicity of a New Brand of E. colil-Asparaginase with Active Host Contaminating Proteins.Effect of Anacardium occidentale leaf extract on human acute lymphoblastic leukaemia cell lines.A comparative structural analysis reveals distinctive features of co-factor binding and substrate specificity in plant aldo-keto reductases.Transgenic Nicotiana tabacum seeds expressing the Mycobacterium tuberculosis Alanine- and Proline-rich antigenAltered expression of noncanonical Wnt pathway genes in paediatric and adult adrenocortical tumoursMiR-708-5p is differentially expressed in childhood acute lymphoblastic leukemia but not strongly associated to clinical featuresPTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination eventsA simplified approach using Taqman low-density array for medulloblastoma subgroupingmRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factorChimerism interpretation with a highly sensitive quantitative PCR method: 6 months median latency before chimerism drop below 0.1.Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT)Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastomaTest trial of spike-in immunoglobulin heavy-chain (IGH) controls for next generation sequencing quantification of minimal residual disease in acute lymphoblastic leukaemiaNRARP displays either pro- or anti-tumoral roles in T-cell acute lymphoblastic leukemia depending on Notch and Wnt signalingMicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matterMonitoring asparaginase activity in middle-income countriesOncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivityThe TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma
P50
Q27304789-ACF00EC0-1DC3-459E-B8C6-B3244207D2F2Q28547020-F3DE23DB-6D52-4D84-B608-7823D8245A5CQ33810422-7EB88741-368F-455D-B13A-05F33C919F65Q35801794-0E5C9CC0-E317-4220-99D4-5AF6E565C803Q36614910-B350265D-5E1D-426A-971F-1D6E10359C15Q37196585-F84ED358-A386-4BA7-9223-885235980806Q38711969-82C32496-317D-4CAC-800F-E955D1C1E4B8Q38770509-0B79D0EC-F84D-4B36-A770-CDDAC7BE09BEQ38814667-83AE2D99-DA63-4CA3-9237-B86647F83458Q38848062-423D4DFE-2237-4304-9656-884E66016A66Q39006513-0F3568B5-9C51-432B-9D1E-DF39B02C1E61Q39070526-14FD69B9-15B0-4971-9AE6-5EE8BB829031Q39202905-11A83D27-9F98-4217-A169-C613DE6D34EAQ39245345-2871FD75-43CA-41FC-81C1-D4D11CBB216AQ41659960-A2EFD2E9-BEAE-4278-942D-B38739ADA993Q41986599-CCCAA0A8-C577-42FF-967F-EB49C8762EBDQ42410421-D72624DA-CDA1-4E29-A72F-00AD5A1D8712Q47581360-1269A55D-4E6E-4423-A93B-80875D587E39Q48519844-52D4B60F-5379-4D60-9CFC-942DE8AEDC0FQ50231931-F8793AAB-4712-49CB-ADA4-865EF6DC7B0BQ50890020-93A14C56-62CF-49DC-B434-9B0FB6A6CB83Q51734172-4C7505BC-C3CC-4511-B94F-3A66E915C1F9Q52650744-58E83860-0F5E-4932-B189-78E3774E4F39Q52714078-09173689-DAE3-4CA9-8BBB-1F74F5B57984Q53106031-8B802D2C-1FF2-4346-8F3F-E100563AE969Q58086175-CB47FF20-E984-4ABC-9214-143451306D66Q60677873-C002DF58-EB6A-45DD-9851-E5E6C56F5447Q61442718-7D193D51-2AA0-4F71-BBCA-1E1B2EDE8D43Q63865765-47AF7BDC-2CCE-4483-8872-91A5C11C020FQ64065929-CBEDA098-5F4E-4ED0-ABA6-4C99E3AA8349Q84816162-C187A4B5-26AF-41BA-8215-42F5E5A8EFF0Q87295579-FE43CFE2-5FF9-4C5E-BE98-B94EC164234AQ87657342-A8F239F4-506E-42B5-9A71-C5B94FC5D9B1Q88877818-73E39016-46A3-4A19-B06C-36E09A010CB8Q90428580-ED878CFE-8F72-4A1C-B706-BF8B1FE69EF4Q90496975-644A2982-4778-4E1E-B954-B28C335E9D57Q90664411-0697B256-4346-4098-819D-77FAE51DA59EQ90761496-823B2A70-54EA-4F62-993A-0251DAEED150Q91167170-F61DD221-2DB4-42C1-9DBC-5404E85628E9Q91289846-32D4BC37-923F-4C35-8A1A-C2E840813D64
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
José Andres Yunes
@en
José Andres Yunes
@nl
type
label
José Andres Yunes
@en
José Andres Yunes
@nl
prefLabel
José Andres Yunes
@en
José Andres Yunes
@nl
P108
P31
P496
0000-0002-1316-3525